Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited)

v3.21.1
Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($)
Series A Convertible Preferred Stock [Member]
Series B Convertible Preferred Stock [Member]
Series C Convertible Preferred Stock [Member]
Series D Convertible Preferred Stock [Member]
Series D-1 Convertible Preferred Stock [Member]
Series Alpha Convertible Preferred Stock [Member]
Common Stock [Member]
Additional Paid-In Capital [Member]
Accumulated Deficit [Member]
Total
Balance at Dec. 31, 2019 $ 24,129 $ 77,077 $ 33,007 $ 15,083 $ 6,435 $ 56,026 $ 45,153,733 $ (46,428,550) $ (1,063,060)
Balance, shares at Dec. 31, 2019 2,412,887 7,707,736 3,300,715 1,508,305 643,511 5,602,214      
Stock-based compensation 7,866 7,866
Net Loss (872,576) (872,576)
Balance at Mar. 31, 2020 $ 24,129 $ 77,077 $ 33,007 $ 15,083 $ 6,435 $ 56,026 45,161,599 (47,301,126) (1,927,770)
Balance, shares at Mar. 31, 2020 2,412,887 7,707,736 3,300,715 1,508,305 643,511 5,602,214      
Balance at Dec. 31, 2020           $ 1 $ 27,296 85,114,755 (66,847,492) 18,294,560
Balance, shares at Dec. 31, 2020           180 27,296,061      
Stock issued upon cash-exercise of warrants           $ 1,320 243,261 244,581
Stock issued upon cash-exercise of warrants, shares           1,319,625      
Stock issued upon net-exercise of warrants           $ 192 (192)
Stock issued upon net-exercise of warrants, shares           192,373      
Stock issued for professional services           $ 25 101,725 101,750
Stock issued for professional services, shares           25,000      
Stock-based compensation           1,262,123 1,262,123
Net Loss           (3,672,627) (3,672,627)
Balance at Mar. 31, 2021           $ 1 $ 28,833 $ 86,721,672 $ (70,520,119) $ 16,230,387
Balance, shares at Mar. 31, 2021           180 28,833,059